Date | Title | Description | |
---|---|---|---|
08 May 2024 | On P&L | The Company releases the press release related to the first three months of 2024 financial results | Download |
25 Apr 2024 | On business and financial situation | ROVI announces agreement to manufacture pre-filled syringes | Download |
27 Feb 2024 | On P&L | The Company releases the press release related to the full year 2023 financial results. | Download |
27 Feb 2024 | On P&L | The Company releases the full year 2023 financial results presentation. | Download |
27 Feb 2024 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
Pages
Date | Title | Description | |
---|---|---|---|
19 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 12 April and 18 April 2024 | Download |
12 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 5 April and 11 April 2024 | Download |
05 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 28 March and 4 April 2024 | Download |
02 Apr 2024 | On business and financial situation | ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia | Download |
29 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 22 March and 27 March 2024 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
03 Jul 2012 | Información sobre dividendos | Download | |
13 Jun 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
26 Apr 2012 | Información sobre resultados (2) | Download | |
26 Apr 2012 | Información sobre resultados | Download | |
26 Apr 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |